Holger Weis
Patrimonio netto: 58 076 $ in data 30/06/2026
Patrimonio netto: 58 076 $ in data 30/06/2026
Holger Weis is the founder of Weis Advisors, Inc., founded in 2018, serving as President & Principal.
Current jobs include Chairman & Chief Executive Officer at Alaunos Therapeutics, Inc. since 2025 and Independent Director at Jupiter Neurosciences, Inc. since 2021.
Former jobs include Chief Financial Officer & Director at Phenotarget Biosciences, Inc. from 2020 to 2021;.
Senior Manager at Ernst & Young LLP from 1986 to 2000; Chief Financial Officer & Treasurer at GMP Cos., Inc. from 2000 to 2005; President, Chief Operating & Financial Officer at DemeRx, Inc. from 2011 to 2017; Chief Financial Officer, Secretary & VP at NovaVision, Inc. from 2006 to 2010; and Chief Financial Officer at EnSA Holdings LLC from 2010 to 2011.
Education includes an undergraduate degree from the University of Georgia, conferred in 1985.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/06/2026 | 16.552 ( 0,68% ) | 37 408 $ | 30/06/2026 | |
| 02/06/2026 | 96.581 ( 0,2% ) | 20 668 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Amministratore Delegato | 02/07/2025 |
| JUPITER NEUROSCIENCES, INC. | Direttore/Membro del Consiglio | 08/09/2021 |
Weis Advisors, Inc. | Fondatore | 01/04/2018 |
| Società | Posizione | Fine |
|---|---|---|
Phenotarget Biosciences, Inc.
Phenotarget Biosciences, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Direttore Finanziario/CFO | 01/03/2021 |
DemeRx, Inc.
DemeRx, Inc. BiotechnologyHealth Technology Provides biotechnology services | Presidente | 24/07/2017 |
EnSA Holdings LLC
EnSA Holdings LLC Miscellaneous Commercial ServicesCommercial Services Provides business of agricultural production and development consulting in the Dominican Republic | Direttore Finanziario/CFO | 01/11/2011 |
NovaVision, Inc.
NovaVision, Inc. Medical/Nursing ServicesHealth Services Provides vision restoration therapy services | Direttore Finanziario/CFO | 01/08/2010 |
GMP Cos., Inc.
GMP Cos., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals, diagnostic products, and medical devices | Direttore Finanziario/CFO | 01/01/2005 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
GMP Cos., Inc.
GMP Cos., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals, diagnostic products, and medical devices | Health Technology |
DemeRx, Inc.
DemeRx, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
NovaVision, Inc.
NovaVision, Inc. Medical/Nursing ServicesHealth Services Provides vision restoration therapy services | Health Services |
University of Georgia
University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
EnSA Holdings LLC
EnSA Holdings LLC Miscellaneous Commercial ServicesCommercial Services Provides business of agricultural production and development consulting in the Dominican Republic | Commercial Services |
Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Weis Advisors, Inc. | |
Phenotarget Biosciences, Inc.
Phenotarget Biosciences, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale